Source: Health Canada shortage reports · Updated Jul 9, 2026
A shortage of Iohexol is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
An iodinated contrast agent used to improve the clarity of X-ray and CT scans.
Products affected
0 / 4
Reports on file
53
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · Production Delay
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Jun 6, 2025 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended May 23, 2025 · Demand increase for the drug.
Resolved
OMNIPAQUE 350
755MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172755 · ended May 2, 2025 · Reason for shortage - manufacturing delay
Resolved
OMNIPAQUE 350
755MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172755 · ended Apr 28, 2025 · Delay in shipping of the drug.
Resolved
OMNIPAQUE 300
647MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172747 · ended Apr 21, 2025 · Delay in shipping of the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Mar 3, 2025 · Reason for shortage: production release delay.
A substitute of same concentration but at a different volume will be offered as an alternative.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Sep 27, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Sep 20, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Jun 11, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended May 3, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Apr 1, 2024 · Demand increase for the drug.
Showing 12 of 53 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Iohexol to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Iohexol is classified under “X-RAY CONTRAST MEDIA, IODINATED” (ATC V08AB).
Recent changes
No changes recorded yet.
Common questions
What is Iohexol used for?
An iodinated contrast agent used to improve the clarity of X-ray and CT scans.
When will Iohexol be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Iohexol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.